In 2024, a large study of over 160,000 individuals showed that GLP-1RAs are associated with a 195% higher risk of major depression, 108% increased risk for anxiety, and 106% elevated risk for suicidal behavior
Peptides are approved to treat a variety of conditions, like maintaining healthy weight and blood sugar in people with type 2 diabetes
It has a short half-life in blood of 1.5-3 min due to a high clearance but also activates afferent nerve endings directly before entering the blood
Several management strategies have been proposed for the early stages of dysglycaemia, with the aim of preventing the development of type 2 diabetes and associated complications, such as CVD
PDFs require Adobe Reader
Manufacturer savings programs can sometimes reduce out-of-pocket cost significantly for patients with commercial insurance